Vanda Pharmaceuticals
VNDA
#8815
Rank
S$0.29 B
Marketcap
S$4.84
Share price
-6.42%
Change (1 day)
-13.73%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -S$0.24 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2025 the company made an earning of -S$0.2 Billion a decrease over its 2024 earnings that were of -S$51.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.24 Billion23.88%
2025 -S$0.2 Billion271.79%
2024 -S$51.95 Million191.43%
2023 -S$17.83 Million-320.45%
2022 S$8.08 M-84.99%
2021 S$53.87 M54.8%
2020 S$34.8 M19.42%
2019 S$29.14 M4.93%
2018 S$27.77 M-228.6%
2017 -S$21.6 Million-8.98%
2016 -S$23.73 Million-53.79%
2015 -S$51.35 Million-30.18%
2014 -S$73.54 Million173.08%
2013 -S$26.93 Million-25.33%
2012 -S$36.07 Million163.61%
2011 -S$13.68 Million-221.15%
2010 S$11.29 M-124.53%
2009 -S$46.04 Million-29.44%
2008 -S$65.24 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$83.95 Million170.55%
2005 -S$31.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.48 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.83 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.82 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$42.92 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.82 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.21 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.59 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA